Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has to meet representatives from the pharmaceutical supply companies to discuss availability issues with hormone replacement therapy products; and when those meetings are scheduled to take place.
The Department regularly discusses the supply of human replacement therapy products with pharmaceutical companies and trade bodies. On 31 March 2022, I met with the Association of the British Pharmaceutical Industry and the British Generic Manufacturers Association to discuss the availability of these products.